Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation

By Durken M.   Herrnring C.   Finckh B.   Nagel S.   Nielsen P.   Fischer R.   Berger H.M.   Moison R.M.W.   Pichlmeier U.   Kohlschutter B.   Zander A.R.   Kohlschutter A.  

Free Radical Biology and Medicine, Vol. 28, Iss. 6, 2000-03 ,pp. : 887-894

Elsevier

Access to resources Recommend Favorite

A Fluorescence-Based One-Step Assay for Serum Non-Transferrin-Bound Iron

By Breuer W.   Cabantchik Z.I.  

Analytical Biochemistry, Vol. 299, Iss. 2, 2001-12 ,pp. : 194-202

Elsevier

Access to resources Recommend Favorite

Pitfalls in Assessing Specificity and Affinity of Non-Transferrin-Bound Iron Uptake

By Brunner-Dopper L.   Kriegerbeckova K.   Kovar J.   Goldenberg H.  

Analytical Biochemistry, Vol. 261, Iss. 1, 1998-07 ,pp. : 128-130

Elsevier

Access to resources Recommend Favorite

Quantification of Non-Transferrin-Bound Iron in the Presence of Unsaturated Transferrin

By Gosriwatana I.   Loreal O.   Lu S.   Brissot P.   Porter J.   Hider R.C.  

Analytical Biochemistry, Vol. 273, Iss. 2, 1999-09 ,pp. : 212-220

Elsevier

Access to resources Recommend Favorite

Sub-lethal levels of amyloid β-peptide oligomers decrease non-transferrin-bound iron uptake and do not potentiate iron toxicity in primary hippocampal neurons

By SanMartín C.  

BioMetals, Vol. 25, Iss. 4, 2012-08 ,pp. : 805-813

Springer Publishing Company

Access to resources Recommend Favorite